Cat allergy got you in mew-sery? This news may change your life fur-ever.

A team of scientists from the Swiss firm HypoPet AG has developed a vaccine to combat the feline-produced protein Fel d 1, to which 10% of humans are allergic, according to their press release.

After analyzing data from four separate studies involving a total of 54 kitties, the antidote, called HypoCat, has already demonstrated its success.

“Our HypoCat vaccine is able to produce high levels of antibodies in cats,” writes Gary Jennings, CEO of HypoPet AG, in the statement. “These antibodies can bind and neutralize the Fel d 1 allergen produced by the animals.”

Researchers say they are “pressing ahead with registration studies and discussions with European and US regulators” to bring the drug to market, which would certainly change lives.

The vaccine would help those with cat allergies avoid typical reactions such as rashes, nasal congestion and irritated eyes, while also lowering their risk of exacerbating asthma or developing chronic respiratory issues.